Edition:
United Kingdom

Evogene Ltd (EVGN.OQ)

EVGN.OQ on NASDAQ Stock Exchange Global Market

3.15USD
20 Jun 2018
Change (% chg)

$0.09 (+2.94%)
Prev Close
$3.06
Open
$3.07
Day's High
$3.15
Day's Low
$3.07
Volume
533
Avg. Vol
3,391
52-wk High
$5.74
52-wk Low
$2.66

Latest Key Developments (Source: Significant Developments)

Evogene Q3 loss per share $0.20
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Evogene Ltd ::Evogene reports third quarter 2017 financial results.Q3 revenue $700,000 versus $1.5 million.Evogene Ltd - ‍in 2018, Evogene expects net cash usage of $14 million to $16 million.Evogene Ltd qtrly loss per share $0.20​.  Full Article

Evogene Qtrly loss per share $0.18
Thursday, 11 Aug 2016 

Evogene Ltd : Evogene reports second quarter 2016 financial results .Q2 revenue $1.8 million versus $2.7 million.  Full Article

BRIEF-Evogene And Marrone Bio Innovations Announce Phase Advancement In Their Insect Control Collaboration

* EVOGENE AND MARRONE BIO INNOVATIONS ANNOUNCE PHASE ADVANCEMENT IN THEIR INSECT CONTROL COLLABORATION

No consensus analysis data available.